Shahzad Waseem.
Cessation of Leakage from Disc Neovascularization in a Patient with Proliferative Diabetic Retinopathy following a Single Intravitreal Bevacizumab injection.
Ophthalmol Update Jan ;12(3):246-246.

Bevacizumab (Avastin) is a recombinant humanized monoclonal IgG1 antibody that inhibits human vascular endothelial growth factor (VEGF). It has been administered intravitreally in VEGF-mediated diseases such as proliferative diabetic retinopathy, choroidal neovascularization1 and central retinal vein occlusion.2 VEGF plays a major role in mediating neovascularization in eyes with proliferative diabetic retinopathy (PDR).3 We describe a patient who had cessation of retinal neovascularization in proliferative diabetic retinopathy, one week following adjunctive intravitreal bevacizumab.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com